Panacea scales up oncology capacity with new Indian facility
This article was originally published in Scrip
Executive Summary
Panacea Biotec, India's second-largest vaccines manufacturer, is scaling up the production of its small molecule oncology drugs. The company has inaugurated a new facility at Baddi, Himachal Pradesh, as part of efforts to meet growing demand for anticancers and also to offer affordable alternatives in the segment to consumers.